The use of tocilizumab in patients with COVID-19: a systematic review, meta-analysis and trial sequential analysis of randomized controlled studies
Background: Among the several therapeutic options assessed for the treatment of
coronavirus disease 2019 (COVID-19), tocilizumab (TCZ), an antagonist of the interleukine …
coronavirus disease 2019 (COVID-19), tocilizumab (TCZ), an antagonist of the interleukine …
Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort
P Ruytinx, P Vandormael, J Fraussen, Z Pieters… - Scientific Reports, 2023 - nature.com
The immune response in patients with Coronavirus Disease 2019 (COVID-19) is highly
variable and is linked to disease severity and mortality. However, antibody and cytokine …
variable and is linked to disease severity and mortality. However, antibody and cytokine …
Efficacy and safety of tocilizumab versus standard care/placebo in patients with COVID‐19; a systematic review and meta‐analysis of randomized clinical trials
Aims Tocilizumab has emerged as an important therapy in treating patients with coronavirus
disease (COVID‐19). Our purpose was to evaluate the efficacy and safety of tocilizumab …
disease (COVID‐19). Our purpose was to evaluate the efficacy and safety of tocilizumab …
The immunology of SARS-CoV-2 infection and vaccines in solid organ transplant recipients
D Dęborska-Materkowska, D Kamińska - Viruses, 2021 - mdpi.com
Since its outbreak in December 2019, the coronavirus disease 2019 (COVID-19) pandemic,
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to an …
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to an …
Influence of extracorporeal cytokine adsorption on hemodynamics in severe acute pancreatitis: results of the matched cohort pancreatitis cytosorbents inflammatory …
S Rasch, S Sancak, J Erber, J Wießner… - Artificial …, 2022 - Wiley Online Library
Background Outcome of severe acute pancreatitis (SAP) highly depends on the degree of
systemic inflammation and organ failure. Although treatment approaches targeting the …
systemic inflammation and organ failure. Although treatment approaches targeting the …
[PDF][PDF] Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan
T Hashimoto, A Murayama, H Mamada, H Saito… - Clinical Microbiology …, 2022 - Elsevier
Since the coronavirus disease 2019 (COVID-19) outbreak in late 2019, evidence on its
treatment has accumulated rapidly. Accordingly, many countries subsequently drafted …
treatment has accumulated rapidly. Accordingly, many countries subsequently drafted …
How to update a living systematic review and keep it alive during a pandemic: a practical guide
Background The covid-19 pandemic has highlighted the role of living systematic reviews.
The speed of evidence generated during the covid-19 pandemic accentuated the …
The speed of evidence generated during the covid-19 pandemic accentuated the …
The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
A Neubauer, J Johow, E Mack, A Burchert, D Meyn… - Leukemia, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19
(coronavirus disease 2019), which is associated with high morbidity and mortality, especially …
(coronavirus disease 2019), which is associated with high morbidity and mortality, especially …
[HTML][HTML] A meta-summary and bioinformatic analysis identified interleukin 6 as a master regulator of COVID-19 severity biomarkers
With the rising demand for improved COVID-19 disease monitoring and prognostic markers,
studies have aimed to identify biomarkers using a range of screening methods. However …
studies have aimed to identify biomarkers using a range of screening methods. However …
High-CBD cannabis extracts inhibit the expression of proinflammatory factors via miRNA-mediated silencing in human small intestinal epithelial cells
The incidence of chronic inflammatory disorders and autoimmune diseases is rapidly
growing. To date, the COVID-19 pandemic caused by SARS-CoV-2 has killed over …
growing. To date, the COVID-19 pandemic caused by SARS-CoV-2 has killed over …